美國
US 12,697,387 B2
Chimeric antigen receptors targeting CD19 and use thereof
US 12,697,387 B2 是美國專利商標局（USPTO）的核准專利，日期 2026-08-04。申請人：MILLENNIUM PHARMACEUTICALS, INC.; MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES; SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH; MEMORIAL SLOAN-KETTERING CANCER CENTER。PDF 可在本頁下載，未登入每天最多 5 篇。
有人下載過這份 PDF 後，這裡會顯示首頁預覽。
- 申請人
- MILLENNIUM PHARMACEUTICALS, INC.; MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES; SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH; MEMORIAL SLOAN-KETTERING CANCER CENTER
- 發明人
- Judith FEUCHT; Jorge MANSILLA-SOTO; Isabelle RIVIERE; Michel SADELAIN; Loic VINCENT; Gary SHAPIRO; Mei Rosa NG; Dan TAVARES; Xingyue HE
- 公開日
- 2026-08-04
- 申請日
- 2022-10-24
- 文件種類
- B2 核准公告
- 也寫作
- US 12,697,387 B2 · US12697387 · 12697387
摘要
The presently disclosed subject matter provides chimeric antigen receptors (CARs) that specifically target CD19 and cells comprising such CD19-targeted CARs. The presently disclosed subject matter further provides uses of the CD19-targeted CARs for treatment, e.g., for treating blood cancer.
這裡只列摘要開頭，完整內容在 PDF 裡。
不用登入，每天可下載 5 篇（今天還剩 5 篇）。批次下載與 OA 引證整理需免費註冊。
專利局網站： 美國專利商標局（USPTO）